Chief Executive Officer Shane Madden and Board Chair Shafin Diamond Tejani will lead the company’s delegation, focusing on discussions surrounding long-term growth and operational momentum. This participation follows a period of significant expansion for the firm, which now manages a network of over 300 physicians and 3,000 nurses across all 50 U.S. states.

Hydreight recently reported record first-quarter 2026 revenue of 24.9 million dollars, marking a 449 percent year-over-year increase. Key operational drivers include the growth of the VSDHOne platform, which has seen its license count climb to over 12,000, and the diversification of its portfolio into 45 distinct healthcare programs, including weight management and hormone health. Management intends to use the conference to detail how these developments, alongside their current peptide healthcare initiatives, position the company to capture further market share.